Murphy Middleton Hinkle & Parker’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,948
Closed -$625K 152
2025
Q4
$625K Buy
+16,948
New +$5.73M 0.3% 83

Other funds holding ELV

Murphy Middleton Hinkle & Parker's ELV Position: Q1 2026 in Review

Murphy Middleton Hinkle & Parker sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 16,948 shares — an estimated $625K sold.

Murphy Middleton Hinkle & Parker first reported a position in ELV in Q4 2025 and held it in 1 quarter. The position peaked at $625K in Q4 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Murphy Middleton Hinkle & Parker reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Murphy Middleton Hinkle & Parker sold 16,948 Elevance Health shares in Q1 2026, an estimated $625K.
  • Murphy Middleton Hinkle & Parker first reported a position in Elevance Health in Q4 2025 and held it in 1 quarter.
  • Murphy Middleton Hinkle & Parker's Elevance Health position peaked at $625K in Q4 2025.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Murphy Middleton Hinkle & Parker's 13F filing for Q1 2026, filed 15 Apr 2026.